PRDSNASDAQHealthcare · Biotechnology

Pardes Biosciences, Inc.

$2.18+0.93%(+$0.02)

TickerSpark Score

62/100

Mixed

Valuation

Profitability

Growth

Health

100

Momentum

Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a PRDS research report →

52-Week Range49% of range

Low $0.75

Current $2.18

High $3.67

Companywww.pardesbio.com

Pardes Biosciences, Inc. , a clinical stage biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics to improve the lives of patients suffering from life-threatening disease. Its lead candidate is the PBI-0451 that is in clinical development stage to treat and prevent severe acute respiratory syndrome coronavirus 2 infections and associated diseases.

CEO: Thomas G. Wiggans
IPO: 2021
Employees: 57
HQ: Carlsbad, CA, US

Price Chart

-34.94% · this period

Valuation

Market Cap: $135.19M
P/E: -1.36
P/S: 0.00
P/B: 0.70
EV/EBITDA: -0.81
Div Yield: 0.00%

Profitability

Gross Margin: 0.00%
Op Margin: 0.00%
Net Margin: 0.00%
ROE: -41.86%
ROIC: -53.57%

Growth & Income

Revenue: $0 · 0.00%
Net Income: $-93,451,000 · -142.43%
EPS: $-1.61 · -136.76%
Op Income: $-99,817,000
FCF YoY: -94.96%

Performance & Tape

52W High: $3.67
52W Low: $0.75
50D MA: $2.03
200D MA: $1.70
Beta: 0.42
Avg Volume: 509.69K

Get TickerSpark's AI analysis on PRDS

Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.

Get Pro Access →

30-day money-back guarantee · cancel anytime

Recent Insider Transactions

Date	Insider	Role	Type	Shares	Value
Aug 31, 23	Tananbaum James B.	director, 10 percent owner, officer: President and CEO	other	1,000	$0.1
Aug 31, 23	Tananbaum James B.	director, 10 percent owner, officer: President and CEO	sell	37,500	$70.13K
Aug 31, 23	Tananbaum James B.	director, 10 percent owner, officer: President and CEO	sell	75,000	$735.00K
Aug 31, 23	Tananbaum James B.	director, 10 percent owner, officer: President and CEO	sell	16,813,146	$1.68K
Aug 31, 23	Tananbaum James B.	director, 10 percent owner, officer: President and CEO	sell	37,500	$195.38K
Aug 31, 23	WIGGANS THOMAS G	director, officer: Chief Executive Officer	other	50,000	$106.50K
Aug 31, 23	WIGGANS THOMAS G	director, officer: Chief Executive Officer	sell	562,500	$1.17M
Aug 31, 23	WIGGANS THOMAS G	director, officer: Chief Executive Officer	sell	985,000	$6.26M
Aug 31, 23	WIGGANS THOMAS G	director, officer: Chief Executive Officer	sell	450,000	$1.34M
Aug 31, 23	Varney Michael David	director	sell	37,500	$70.13K